A Phase III Randomized Study to Evaluate the Efficacy and Safety of CT-P13 Compared With Reference Infliximab in Patients With Active Rheumatoid Arthritis: 54-Week Results From the PLANETRA Study
Arthritis Research & Therapy
doi 10.1186/s13075-016-0981-6
Full Text
Open PDFAbstract
Available in full text
Date
April 2, 2016
Authors
Publisher
Springer Science and Business Media LLC